 |
Title
|
|
|
|
Phase 
|
|
|
|
Protocol IDs
|
|
|
| |
Correlation Between SV2A Expression in Tumour Tissue and Efficacy of Levetiracetam in Glioma Patients With Epilepsy
|
|
|
|
Phase IV
|
|
|
|
EPI-GLIO-LEV
NCT00454935
|
|
| |
Trial of Levetiracetam in Patients With Primary Brain Tumors and Symptomatic Seizures Who Undergo Surgery
|
|
|
|
Phase IV
|
|
|
|
HELLO-Study 2007
EudraCT Number: 2007-005063-96, NCT00571155
|
|
| |
Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Cancer or Suspected Cancer
|
|
|
|
Phase III, Phase II
|
|
|
|
SP-11-0035
NCT00123760
|
|
| |
Phase II/III Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM)
|
|
|
|
Phase III, Phase II
|
|
|
|
Protocol CDX110-003
NCT00458601
|
|
| |
Temozolomide Compared to Procarbazine, Lomustine, and Vincristine in Treating Patients With Recurrent Malignant Glioma
|
|
|
|
Phase III
|
|
|
|
MRC-BR12
EU-20114, ISRCTN83176944, NCT00052455
|
|
| |
Human Corticotropin-Releasing Factor in Controlling Symptoms Associated With Brain Swelling in Patients With Malignant Brain Tumors
|
|
|
|
Phase III
|
|
|
|
NTI-0303
BCM-H-14962, NCT00088166
|
|
| |
Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer
|
|
|
|
Phase III
|
|
|
|
RTOG-0320
RTOG-0320, NCT00096265
|
|
| |
A Trial Comparing Radiosurgery With Surgery for Solitary Brain Metastases
|
|
|
|
Phase III
|
|
|
|
021108
NCT00124761
|
|
| |
Radiation Therapy or Temozolomide in Treating Patients With Gliomas
|
|
|
|
Phase III
|
|
|
|
EORTC-22033
EORTC-26033, EudraCT-2004-002714-11, CAN-NCIC-CE5, NCT00182819, TROG 06.01, CE5
|
|
| |
Brain Metastases Study: Radiotherapy Fractionation Schemes in the Treatment of Brain Metastases
|
|
|
|
Phase III
|
|
|
|
95/29 Graham
NCT00138788
|
|
